HomeOwner SearchCategory Search
Visit USCOPharmacovigilance Argus: Breaking New Ground in Clinical Trial Safety
Text Registration
Copyright Title
Pharmacovigilance Argus: Breaking New Ground in Clinical Trial Safety
Status
Published
on 12 May 2016
Year of Creation
2016
Copyright Claimant
Joakim Lindroos
Registration Number
TX0008268142
on 12 May 2016Copyright Summary
The U.S. Copyright record (Registration Number: TX0008268142) dated 12 May 2016, pertains to an electronic file (eService) titled "Pharmacovigilance Argus: Breaking New Ground in Clinical Trial Safety" created in 2016. The copyright holder is Joakim Lindroos, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Joakim Lindroos.
Application Details
Registration Number
TX0008268142
Registration Date
5/12/2016
Year of Creation
2016
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States
Notes
Rights Note: Premier Research, One Park Drive, Durham, NC, 27709, United States
Statements
Application Title Statement: Pharmacovigilance ARGUS Safety Database_Fact Sheet
Author Statement: Joakim Lindroos (author of anonymous contribution) Domicile: Canada Authorship: text
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.